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Seizures are known to occur in Creutzfeldt–Jakob disease (CJD). In the setting of a rapidly progressive condition
with no effective therapy, determining appropriate treatment for seizures can be difﬁcult if clinical morbidity is
not obvious yet the electroencephalogram (EEG) demonstrates a worrisome pattern such as status epilepticus.
Herein, we present the case of a 39-year-old man with CJD and electrographic seizures, discuss how this case
challenges conventional deﬁnitions of seizures, and discuss a rational approach toward treatment. Coincidentally,
our case is the ﬁrst report of CJD in a patient with Stickler syndrome.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
While rare, there are increasing reports of seizures occurring in
patients with Creutzfeldt–Jakob disease (CJD) [1–14]. When there is
obvious clinical morbidity, the decision to treat seizures is straightfor-
ward. However, in cases where clinical morbidity is not obvious yet
the electroencephalogram (EEG) demonstrates a worrisome pattern,
treatment decisions become difﬁcult, especially in a rapidly progressive
condition for which there is no effective disease-modifying therapy.
Neurologists and epileptologists will increasingly face this question as
the index of suspicion for seizures in CJD rises, as more inpatients
undergo long-term EEG monitoring, and as the formal deﬁnition of a
seizure continues to evolve. To highlight these issues, we discuss the
case of a patient with CJD and electrographic seizures. Coincidentally,
our case is also the ﬁrst ever report of CJD occurring in a patient
with Stickler syndrome, a rare autosomal dominant connective tissue
disorder [15].
2. Case report
A 39-year-old right-handed man was seen at a tertiary otolaryngol-
ogy center for worsening lightheadedness. This symptom had devel-
oped over one month after his son was diagnosed with Stickler
syndrome type I, of which the patient was a carrier as proven by genetic
testing. Speciﬁcally, the patientwas heterozygous for a 2-base-pair mu-
tation (AG) on exon 41 of the COL2A1 gene which led to a frameshift
mutation, a subsequent premature downstream termination codon,
and, ultimately, a null allele. The patient's only possible clinicalmanifes-
tation was myopia.
His lightheadedness was initially attributed to anxiety related to his
recent diagnosis and myopia. Nevertheless, his symptoms worsened,
and he sought medical attention within days because he started
experiencing “foggy thinking” and his wife reported episodic word-
ﬁnding difﬁculty. Neurological examination showed no focal deﬁcits,
but there was “mild cognitive slowing”. He was ultimately discharged
without intervention.
Within days, however, he returned and was admitted because of
inability to care for himself. Complete blood count, electrolyte levels,
glucose level, renal and liver function, erythrocyte sedimentation rate,
and C-reactive protein level were all within normal laboratory range.
Serum toxicology, infectious disease, and paraneoplastic antibody
panels were negative. A urine toxicology panel was similarly negative.
Cerebrospinal ﬂuid examination was unremarkable, including a nega-
tive assay for 14-3-3 protein. Serum thyroid peroxidase antibodies
were elevated (up to 812 IU/mL), prompting an empiric week-long
trial of daily high-dose intravenous methylprednisolone for possible
steroid responsive encephalopathy with autoimmune thyroiditis;
however, he showed no clinical improvement.
Because the patient had unexplained altered mental status, he
underwent long-term EEG monitoring at the start of admission which
revealed sharp generalized periodic discharges with a triphasic mor-
phology at a frequency of 1 Hz with greater amplitude on the left
(Fig. 1). Brain MRI demonstrated prominent diffusion restriction in the
cortical ribbon of the left hemisphere and in the caudate nuclei bilater-
ally (Fig. 2).
Over a2- to3-weekperiod, hedevelopedprogressive lightheadedness,
sleep disturbances, and cognitive difﬁculty to the point where he was
only able to blink once for yes and twice for no. He also exhibited an ex-
aggerated startle response and became bedridden. With worsening
mental status, a repeat EEG disclosed recurrent runs lasting up to 60 s
of spike and wave activity arising from a quiescent background and
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evolving in frequency from 0.5 Hz to a maximum of 2 Hz before termi-
nating abruptly (Fig. 3). As there was no deﬁnite clinical correlate, this
pattern was thought to represent an electrographic (subclinical)
seizure.
Based on the clinical diagnosis of CJD and his rapid clinical deteriora-
tion, his family refused further treatment, and he died one month after
hospital admission. Autopsy conﬁrmed the diagnosis of sporadic CJD
(Fig. 4).
3. Discussion
Our case highlights two main issues in the treatment of seizures in
CJD. Firstly, the question arises over whether the EEG patterns in ques-
tion are truly seizures. In case reports, the criteria used for diagnosing
seizures in CJD have varied. Some have deﬁned seizures as EEG patterns
with a deﬁnite clinical correlate — most often motoric and focal as in
epilepsia partialis continua [1–4]. Others have deﬁned seizures based
on EEG patterns concomitant with altered mental status [5–10]. Of
these reports, one study further required combined electroclinical im-
provement (i.e., improved mental status) resulting from antiepileptic
drug (AED) administration [5], while two utilized the evolution of the
electrographic pattern as an additional diagnostic criterion [6,7].
We chose to deﬁne seizure in our case report based on accepted
EEG-based criteria for an electrographic seizure [16,17]. Our patient
had electrographic events all without a clinical correlate. These
events lasted longer than 10 s and increasingly evolved in frequency
from 0.5 Hz to 2 Hz. It is worth noting, however, that modern EEG
criteria for deﬁning ictal events have largely been developed in the
context of critical care monitoring. Whether they are relevant in a
progressive degenerative disease remains a topic for debate.
The second issue highlighted by this case is whether electrographic
seizures should be treated. No AEDs have ever been shown to alter the
terminal trajectory of CJD [1–14]. Only two reports have noted transient
clinical improvement with AEDs [5,11]. Other reports of seizures in
CJD using pharmacological agents (e.g., propofol, midazolam) geared
toward electrographic burst suppression did not result in clinical
improvement — not even transiently [6–8]. In our patient, treating his
electrographic seizures seemed unlikely to alter his relentless downhill
course and was rejected by his family.
Our case suggests that given the terminal trajectory of CJD at the
present time, treating seizures in CJD requires ﬁrst a concerted and
thoughtful attempt to deﬁne seizures as rigorously as possible. Once a
seizure has been ﬁrmly identiﬁed, then there must be judicious consid-
eration of the clinical risks and beneﬁts of any AED intervention. In CJD,
much like any other medical condition, not all seizures are alike, not all
seizures merit treatment, and there is no substitute for clinical acumen.
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Fig. 2. a. DWI and ADC images of MRI with DWI demonstrating diffusion restriction in the cortical ribbon diffusely within the left hemisphere. b. DWI and ADC images of MRI with DWI
demonstrating diffusion restriction in the bilateral caudate nuclei and the cortical ribbon diffusely within the left hemisphere.
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Fig. 3. a. Onset of electrographic seizure with generalized spike–wave complexes evolving out of quiescent background and increasing in frequency from 0.5 Hz to 1 Hz. b. In themidst of
the same electrographic seizure with generalized spike–wave complexes at a frequency of 2 Hz. c. End of the same electrographic seizure with termination of generalized spike–wave
complexes and resumption of background activity.
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Fig. 4. a. Frontal cortex (LH&E stain) showing marked spongiform change at 10× magni-
ﬁcation. b. Frontal cortex (LH&E stain) showing marked spongiform change, vacuoles,
and reactive gliosis at 40× magniﬁcation.
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